rx revu investor_v4
TRANSCRIPT
![Page 1: Rx revu investor_v4](https://reader035.vdocuments.us/reader035/viewer/2022062220/5590c2c91a28ab54558b45b6/html5/thumbnails/1.jpg)
The Institute for Cost-Effective Medicine
rev. 4.22.13
![Page 2: Rx revu investor_v4](https://reader035.vdocuments.us/reader035/viewer/2022062220/5590c2c91a28ab54558b45b6/html5/thumbnails/2.jpg)
Kevin O’Brien, MDExecutive Director
Physician with 25 years of clinical experience. In the 90s Dr. O’Brien created several disease management programs for health plans (Kaiser Permanente, Anthem, Humana, Prudential, and others). Medical Director of one of the nation’s largest medical education companies, with the responsibility of developing physician and patient education programs, and doing focus interviews with hundreds of physicians and patients regarding prescription medicine preferences.
Carm HuntressBusiness Development
Product development expert and strategic leader with over 15 years experience in startups and midsized companies. Broad skills across numerous disciplines include: product development, web marketing, strategic planning, early stage products, and budgeting. Carm’s technical background combined with his ability to manage teams give him the ability to create robust products that are highly successful and quickly adopted by end-users.
Daniel CaronMarketing Officer
A programmer and marketer, Dan has successfully launched three 7 figure consumer products, the highest grossing 3.5 million in 24 hours. Dan has since gone on to develop several highly effective marketing tactics, derived from his research into neuroscience and on the human brain. Has built several multi-million dollar Internet Businesses, is a frequent speaker, and continues to refine his ability to generate sales and drive adoption for his online businesses.
Introduction – RxRevu Team
![Page 3: Rx revu investor_v4](https://reader035.vdocuments.us/reader035/viewer/2022062220/5590c2c91a28ab54558b45b6/html5/thumbnails/3.jpg)
Problem
NO TIME for Doctors to address the cost of medications
Medication COSTS ARE RISING 10% year over year
LACK OF TRANSPARENCY around cost effective alternatives
![Page 4: Rx revu investor_v4](https://reader035.vdocuments.us/reader035/viewer/2022062220/5590c2c91a28ab54558b45b6/html5/thumbnails/4.jpg)
The Prescription Drug Market
• 150M Americans on medications • 25% of 18-39 on two or more• 25% of seniors on five or more
• $300 billion spent annually • 4.02 billion prescriptions in 2011
• 5200 medications on the market
![Page 5: Rx revu investor_v4](https://reader035.vdocuments.us/reader035/viewer/2022062220/5590c2c91a28ab54558b45b6/html5/thumbnails/5.jpg)
Prescription Drugs and Cost
• $36B in overspending on medications• Due to costly prescribing by physicians
• Insufficient information• 47% of doctors talk about costs• 35% of patients don’t ask about costs
• 10% yr-over-yr cost increases until 2020• No Transparency
• Even though the data is available
![Page 6: Rx revu investor_v4](https://reader035.vdocuments.us/reader035/viewer/2022062220/5590c2c91a28ab54558b45b6/html5/thumbnails/6.jpg)
RxRevu Solution
Insurance Plans
Medication Data
Retail Costs
Research on Efficacy(3 yrs of research)
Medication Cost Alternatives Report
RxRevuChoice
Algorithm
![Page 7: Rx revu investor_v4](https://reader035.vdocuments.us/reader035/viewer/2022062220/5590c2c91a28ab54558b45b6/html5/thumbnails/7.jpg)
Report Benefits
• Displays members current medications • Clearly shows alternatives and cost savings• Includes efficacy information for doctors• Member brings to next doctors visit• Delivery Options:
• By mail or email• Automated report generation (seniors)• Offered directly through website
(white labeled)• API• Mobile
![Page 8: Rx revu investor_v4](https://reader035.vdocuments.us/reader035/viewer/2022062220/5590c2c91a28ab54558b45b6/html5/thumbnails/8.jpg)
Demonstration
Boniva 150 mg
https://vimeo.com/64478107
![Page 9: Rx revu investor_v4](https://reader035.vdocuments.us/reader035/viewer/2022062220/5590c2c91a28ab54558b45b6/html5/thumbnails/9.jpg)
Current Customers Pilots
![Page 10: Rx revu investor_v4](https://reader035.vdocuments.us/reader035/viewer/2022062220/5590c2c91a28ab54558b45b6/html5/thumbnails/10.jpg)
Target Markets
• Health Plans• Reduces pharma costs• Improves communication
• Self Insured Companies • Lowers claims and insurance costs
• Service Providers• Value-add to existing software• Improves physician knowledge
• Patients/Physicians• Lowers medication costs• Improves adherence• Proactive tool for cost savings
![Page 11: Rx revu investor_v4](https://reader035.vdocuments.us/reader035/viewer/2022062220/5590c2c91a28ab54558b45b6/html5/thumbnails/11.jpg)
Current Milestones
• Research completed• Launched website• Landed 4 customers and 2 pilots
in less than 3 months• Built Team• Automating the process to scale
business
![Page 12: Rx revu investor_v4](https://reader035.vdocuments.us/reader035/viewer/2022062220/5590c2c91a28ab54558b45b6/html5/thumbnails/12.jpg)
Current Objectives
• Complete Trials• Show definitive RIO with members at scale
• Team Building• Application Developer• Sales/Marketing
• Seek funding to automate process and scale• 300k for 12-18 months of operational coverage
![Page 13: Rx revu investor_v4](https://reader035.vdocuments.us/reader035/viewer/2022062220/5590c2c91a28ab54558b45b6/html5/thumbnails/13.jpg)
Next Steps
Comments, Questions, Next Steps…